Summary
The distribution and composition of lipoproteins spanning the very low density and low density lipoprotein spectra have been analysed in ten poorly-controlled, male, Type 2 (non-insulin-dependent), diabetic patients pre-disposed to mild, secondary hypertriglyceridaemia. As compared to age-matched control subjects, the diabetic patients displayed grossly modified, distinctly atherogenic lipoprotein profiles. Modifications were not limited to the very low density lipoprotein profile, as would be expected from the pre-treatment hypertriglyceridaemia. There was also an aberrant low density lipoprotein profile, which was not evident from plasma cholesterol measurements, especially as the diabetic patients at entry were well matched to control subjects with respect to plasma levels of this lipid. Compositional abnormalities were also observed in the poorly-controlled diabetic group, although these were less marked than the distributional changes. There were substantial improvements of the abnormalities detailed above, even over a short treatment period (two weeks), with therapy designed primarily to ameliorate metabolic control. The data suggest that, in the presence of poor metabolic control and hypertriglyceridaemia, occult, atherogenic modifications of low density lipoproteins can occur. The results argue in favour of strict control of triglyceride levels even in diabetic patients with apparently acceptable cholesterol levels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gibbons GF (1986) Hyperlipidaemia of diabetes. Clin Sci 71: 477–486
Howard BV (1987) Lipoprotein metabolism in diabetes. J Lipid Res 28: 613–628
Betteridge DJ (1989) Lipids, diabetes, and vascular disease: the time to act. Diabetic Med 6: 195–218
Reardon MF, Fidge NH, Nestel PJ (1978) Catabolism of very low density lipoprotein in man. J Clin Invest 61: 850–860
Janus ED, Nicoll A, Wootton R, Turner PR, Magill PJ, Lewis B (1981) Quantitative studies of very low density lipoprotein conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest 10: 149–160
Nikkila EA (1984) HDL in relation to the metabolism of triglyceride-rich lipoproteins. In: Miller NE, Miller GJ (eds) Clinical and metabolic aspects of high density lipoproteins. Elsevier, Amsterdam, pp 217–274
Reichl D, Miller NE (1989) Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9: 785–797
Austin MA (1989) Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 129: 249–259
Castelli WP (1986) The triglyceride issue: a view from Framingham. Am Heart J 112: 432–437
Study group, European Atherosclerosis Society (1988) The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart J 9: 571–600
Fisher WR, Zech LA, Bardalage P, Warmke G, Berman M (1980) The metabolism of apolipoprotein B in subjects with hypertriglyceridaemia and polydisperse LDL. J Lipid Res 21: 760–774
Packard CJ, Shepherd J, Joerns S, Gotto AM Jr, Taunton OD (1979) Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinaemia. Chemical and physical properties. Biochem Biophys Acta 572: 269–282
Packard CJ, Munro A, Lorimer AR, Gotto AM Jr, Shepherd J (1984) Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74: 2178–2192
Lindgren FT, Jensen LC, Hatch FT (1972) The isolation and quantitative analysis of serum lipoproteins. In: Nelson GJ (ed) Blood lipids and lipoproteins. Quantitation, composition and metabolism. Wiley Interscience, New York, pp 182–274
James RW, Pometta D (1990) Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 39: 1158–1164
James RW, Pometta D (1990) Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis 83: 35–45
Lowry OH, Rosebrough NJ, Farr AL, Randall PJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Kane JP, Sata T, Hamilton RL, Havel RJ (1975) Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest 56: 1622–1634
Leowsky J, James RW, Taton J, Pometta D (1988) The influence of metabolic control on very low density lipoprotein composition in hypertriglyceridaemic type II diabetics. A study using heparin-sepharose chromatography. Metabolism 37: 721–726
Stender S, Zilversmit DB (1981) Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits: molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis 1: 38–49
Howard BV, Abbott WGH, Beltz WF, Harper IT, Fields RM, Grundy SM, Taskinen M-R (1987) Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36: 870–877
Brewer HB (1983) Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Int Med 98: 623–664
Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, Detre KM, Levy RI (1987) Intermediate density lipoproteins and coronary heart disease progression in hypercholesterolaemic men. Lancet II: 62–66
Yoshino G, Kazumi T, Iwai M, Matsuba K, Iwatani I, Matsushita M, Kasama T, Baba S (1988) Recommendations for strict control of plasma triglycerides in diabetic subjects. Diabetes Care 11: 794–795
Musliner TA, Krauss RM (1988) Lipoprotein subspecies and risk of coronary disease. Clin Chem 34: B 78-B 83
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917–1921
Weisweiler P, Schwandt P (1987) Type I (insulin-dependent) versus type 2 (non-insulin dependent) diabetes mellitus: characterisation of serum lipoprotein alterations. Eur J Clin Invest 17: 87–91
Joven J, Vilella E, Costa B, Turner PR, Richart C, Masana L (1989) Concentrations of lipids and apolipoproteins in patients with clinically well controlled insulin dependent and non-insulin dependent diabetes. Clin Chem 35: 813–816
Kasama T, Yoshino G, Iwatani I, Iwai M, Hatakana H, Kazumi T, Oimomi M, Baba S (1987) Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidaemic non-insulin-dependent diabetes. Atherosclerosis 63: 263–266
Fisher W (1983) Heterogeneity of plasma low density lipoproteins: manifestations of the physiologic phenomenon in man. Metabolism 32: 283–291
Austin MA, Krauss RM (1986) Genetic control of low density lipoprotein subclasses. Lancet II: 592–595
Austin MA, King M-C, Vranizan KM, Newman B, Krauss RM (1988) Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 43: 838–846
Tall A (1986) Plasma lipid transfer proteins. J Lipid Res 27: 361–367
Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S (1984) Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4: 225–231
Bagdade JD, Buchanan WE, Kuusi T, Taskinen M-R (1990) Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 10: 232–239
Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J (1988) Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 29: 1603–1611
Rivellese A, Riccardi G, Romano G, Giacco R, Patti L, Marotta G, Annuzzi G, Mancini M (1988) Presence of very low density lipoprotein compositional abnormalities in Type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation. Diabetologia 31: 884–888
Laakso M, Pyörälä K (1990) Adverse effects of obesity on lipid and lipoprotein levels in insulin dependent and non-insulin dependent diabetes. Metabolism 39: 117–122
Denke MA, Grundy SM (1989) Treatment of diabetic dyslipidaemia. Biochem Soc Trans 17: 56–58
Grundy SM, Denke MA (1990) Dietary influence on serum lipids and lipoproteins. J Lipid Res 31: 1149–1172
Mancini M, Mattock M, Rabaya E, Chait A, Lewis B (1973) Studies of the mechanisms of carbohydrate-induced lipaemia in normal man. Atherosclerosis 17: 445–454
Ishibashi S, Yamada N, Shimano H, Takaku F, Akanuma Y, Murase T (1989) Composition of very low density lipoproteins in non-insulin dependent diabetes mellitus. Clin Chem 35: 808–812
Billingham MS, Milles JJ, Bailey CJ, Hall RA (1989) Lipoprotein subfraction composition in non-insulin dependent diabetes treated by diet, sulphonylurea, and insulin. Metabolism 38: 850–857
Gabor J, Spain M, Kalant N (1980) Composition of serum very-low-density and high-density lipoproteins in diabetes. Clin Chem 2: 1261–1265
Stalenhoef AFH, Demacker PNM, Lutterman JA, Van't Laar A (1982) Apolipoprotein C in Type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Diabetologia 22: 489–491
Fontbonne A, Eschwège E, Cambien F et al. (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32: 300–304
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
James, R.W., Pometta, D. The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34, 246–252 (1991). https://doi.org/10.1007/BF00405083
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00405083